Upload Avatar (500 x 500)
Xu Yan
Bioinformatics Science and Technology
Harbin Medical University
Heilongjiang
Language: Chinese, English
Cancer
Bioinformatics
Non-Coding Rna
Transcription Factors
Co-Regulation
Multi-Omics
Tumor
Drug Resistance
Single-Cell Sequencing
Mechanisms
Areas of Focus
- Cancer Bioinformatics
- Non-coding RNA and Transcription Factors in Cancer
- Cancer Interaction and Co-regulation Mechanisms
- Tumor Drug Resistance Molecular Mechanisms
Work Experience
- Current - Harbin Medical University - Director of the Department of Biomedical Engineering
Publications
- Upregulation of CXCL1 and LY9 contributes to BRCAness in ovarian cancer and mediates response to PARPi and immune checkpoint blockade, Xu Yan, 2022
- Strongly preserved modules between cancer tissue and cell line contribute to drug resistance analysis across multiple cancer types, Xu Yan, 2021
- Identification of Primary and Metastatic Lung Cancer-Related lncRNAs and Potential Targeted Drugs Based on ceRNA Network, Xu Yan, 2021
- An individualized transcriptional signature to predict the epithelial-mesenchymal transition based on relative expression ordering, Xu Yan, 2020
- Identification and Characterization of the Copy Number Dosage-Sensitive Genes in Colorectal Cancer, Xu Yan, 2020
- Systematic identification of dysregulated lncRNAs associated with platinum-based chemotherapy response across 11 cancer types, Xu Yan, 2020
- Optimization of cell lines as tumour models by integrating multi-omics data, Xu Yan, 2017
- An integrated approach to reveal miRNAs’ impacts on the functional consequence of copy number alterations in cancer, Xu Yan, 2015
- CNVD: Text Mining-based Copy Number Variation in Disease Database, Xu Yan, 2012
Awards
- Heilongjiang Provincial Higher Education Science and Technology Award Second Prize (First)
